| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Isabelle Bedrosian | |
| Katharine Yao | |||
| Mark Sisco | |||
| P2860 | cites work | Temporal Trends in and Factors Associated With Contralateral Prophylactic Mastectomy Among US Men With Breast Cancer | Q86056259 |
| Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction | Q86872116 | ||
| Clinical management factors contribute to the decision for contralateral prophylactic mastectomy | Q95479967 | ||
| Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment | Q23922894 | ||
| Prophylactic mastectomy for the prevention of breast cancer | Q24246119 | ||
| Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study | Q30415050 | ||
| Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002. | Q30692732 | ||
| Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: a report from the National Cancer Data Base | Q30799663 | ||
| Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base | Q30826866 | ||
| Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base | Q30853611 | ||
| Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base | Q30966886 | ||
| Survival in hereditary breast cancer associated with germline mutations of BRCA2. | Q33179111 | ||
| Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. | Q33576049 | ||
| Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma | Q33707182 | ||
| Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. | Q33964848 | ||
| Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy | Q34113473 | ||
| International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers | Q34116505 | ||
| Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer | Q34193309 | ||
| Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. | Q34436508 | ||
| Declining incidence of contralateral breast cancer in the United States from 1975 to 2006 | Q34866230 | ||
| Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. | Q35023352 | ||
| RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation | Q35102484 | ||
| Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy | Q35120228 | ||
| Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer | Q35170200 | ||
| Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials | Q35186747 | ||
| Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis | Q35192288 | ||
| Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients | Q35555279 | ||
| Online tool to guide decisions for BRCA1/2 mutation carriers | Q35808372 | ||
| Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy | Q35838312 | ||
| Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation | Q35945018 | ||
| Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project | Q36082407 | ||
| Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer | Q36137506 | ||
| Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status | Q36339415 | ||
| Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance | Q81308162 | ||
| Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients | Q83586270 | ||
| Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution | Q84024696 | ||
| Increasing incidence of bilateral mastectomies: the patient perspective | Q84044995 | ||
| Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses | Q84356681 | ||
| Perceptions of contralateral breast cancer: an overestimation of risk | Q84986718 | ||
| CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer | Q36449203 | ||
| Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy | Q36770162 | ||
| Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics | Q37069660 | ||
| Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer | Q37151892 | ||
| Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging | Q37325069 | ||
| Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer | Q37613953 | ||
| Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits | Q37661116 | ||
| Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer | Q37661126 | ||
| Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey | Q37669779 | ||
| Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. | Q38029521 | ||
| Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer | Q38104524 | ||
| Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy | Q38451140 | ||
| Clinicopathologic features and time interval analysis of contralateral breast cancers | Q38525573 | ||
| Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer | Q39150355 | ||
| Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer | Q40419305 | ||
| Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer | Q40726972 | ||
| The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis. | Q40910371 | ||
| Increasing patient involvement in choosing treatment for early breast cancer | Q40964418 | ||
| Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer | Q41088085 | ||
| Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial | Q42801121 | ||
| Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ | Q43523112 | ||
| Operative risks associated with contralateral prophylactic mastectomy: a single institution experience | Q43605887 | ||
| Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis | Q43677630 | ||
| Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer | Q44032253 | ||
| Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy | Q44244138 | ||
| Nationwide trends in mastectomy for early-stage breast cancer | Q44729377 | ||
| Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. | Q44946113 | ||
| Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database | Q45402820 | ||
| Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands | Q45897710 | ||
| Issues of regret in women with contralateral prophylactic mastectomies. | Q45899108 | ||
| Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy. | Q46039712 | ||
| Quality of life after bilateral prophylactic mastectomy | Q46127741 | ||
| Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy | Q46308502 | ||
| Survival analysis of contralateral prophylactic mastectomy: a question of selection bias | Q46442172 | ||
| Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group | Q47189470 | ||
| Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer | Q48082941 | ||
| Contralateral prophylactic mastectomy in breast cancer patients with a family history: a prospective 2-years follow-up study of health related quality of life, sexuality and body image. | Q48429069 | ||
| Reconstructive outcomes in patients undergoing contralateral prophylactic mastectomy | Q48560990 | ||
| Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. | Q50544542 | ||
| Increasing rates of contralateral prophylactic mastectomy - a trend made in USA? | Q50969644 | ||
| Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. | Q51068059 | ||
| Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. | Q51069895 | ||
| Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. | Q51579519 | ||
| Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. | Q51622407 | ||
| Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. | Q51842226 | ||
| The Influence of Preoperative MRI on Breast Cancer Treatment | Q56989570 | ||
| Trust and Sources of Health Information | Q57410427 | ||
| Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery | Q58854488 | ||
| ‘Taking Control of Cancer’: Understanding Women’s Choice for Mastectomy | Q58877334 | ||
| Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study | Q59265015 | ||
| NIH consensus conference. Treatment of early-stage breast cancer | Q68176587 | ||
| Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial | Q68201092 | ||
| Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials | Q71523388 | ||
| Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival | Q73159881 | ||
| Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study | Q73580673 | ||
| Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy | Q73986452 | ||
| Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer | Q78410812 | ||
| Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007 | Q80539875 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obstetrics and gynaecology | Q80015 |
| P304 | page(s) | 213-23 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | International Journal of Women's Health | Q6051629 |
| P1476 | title | Contralateral prophylactic mastectomy: current perspectives | |
| P478 | volume | 8 |
| Q51058808 | Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy. |
| Q50077911 | Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer |
| Q91985263 | Increasing Role of Oncoplastic Surgery for Breast Cancer |
| Q52604887 | Risk-reducing mastectomy for the prevention of primary breast cancer. |
| Q58696819 | Surgery for , TP53 and PALB2: a literature review |
| Q89302687 | Trends in breast reconstruction practices in a specialized breast tertiary referral centre |
| Q64941163 | Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network. |
Search more.